Juvenile myelomonocytic leukemia; moving forward.
M Tarek Elghetany, Hélène Cavé, Rita De Vito, Mrinal M Patnaik, Eric Solary, Joseph D Khoury
Author Information
- M Tarek Elghetany: Department of Pathology & Immunology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. txelghet@texaschildrens.org. ORCID
- Hélène Cavé: Université Paris Cité, Institut de recherche Saint-Louis and the Department of Genetics, Robert Debré Hospital, Paris, France. ORCID
- Rita De Vito: Pathology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, Rome, Italy.
- Mrinal M Patnaik: Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. ORCID
- Eric Solary: Department of Hematology, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. ORCID
- Joseph D Khoury: Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. ORCID
No abstract text available.
- Niemeyer CM, Rudelius M, Shimamura A, Flotho C, Hasle H, Stieglitz E, et al. Classification of rare pediatric myeloid neoplasia-Quo vadis? Leukemia. 2022;36:2947–8.
[DOI: 10.1038/s41375-022-01731-w]
- Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.
[DOI: 10.1038/s41375-022-01613-1]
- Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.
[DOI: 10.1182/blood.2022015850]
- Alaggio R, Carneiro F, Chan JKC, Cheung ANY, Cree IA, Denton E, et al. (Eds), WHO Classification of Tumours: Paediatric tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022 [cited 2022/11/22]. (WHO Classification of Tumours series, 5th ed.; vol. 7). Available from: https://tumourclassification.iarc.who.int/chapters/44 .
- Strullu M, Caye A, Cassinat B, Fenneteau O, Touzot F, Blauwblomme T, et al. In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia. Leukemia. 2013;27:2404–7.
[DOI: 10.1038/leu.2013.203]
- Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds): WHO classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon 2001.
- Swerldow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (Eds): WHO classification of tumours of haematopoietic and lymphoid tissues, IARC: Lyon 2008.
- Swerldow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (Eds): WHO classification of tumours of haematopoietic and lymphoid tissue (revised 4th edition), IARC: Lyon 2017.
- Kanayama T, Imamura T, Kawabe Y, Osone S, Tahara J, Iwasaki F, et al. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia. Int J Hematol. 2018;108:665–9.
[DOI: 10.1007/s12185-018-2522-3]
- Schwatrz JR, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8:1557.
[DOI: 10.1038/s41467-017-01590-5]
- Hecht A, Meyer JA, Behnert A, Wong E, Chehab F, Olshen A, et al. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia. Haematologica 2022;107:178–86.
[DOI: 10.3324/haematol.2020.270595]
Humans
Leukemia, Myelomonocytic, Juvenile
